NovoCure LimitedNovoCure LimitedNovoCure Limited

NovoCure Limited

No trades
See on Supercharts

Price target

33.000.000.00%
The 7 analysts offering 1 year price forecasts for NVCR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to NVCR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NVCR EPS for the last quarter is −0.28 USD despite the estimation of −0.33 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of NovoCure Limited financials and stay on top of what is up with the company.
In the next quarter NovoCure Limited revenue is expected to reach ‪153.04 M‬ USD. Check out NovoCure Limited revenue and earnings and make informed decisions.
According to analysts, NVCR price target is 33.00 USD with a max estimate of 40.00 USD and a min estimate of 28.00 USD. Check if this forecast comes true in a year, meanwhile watch NovoCure Limited stock price chart and keep track of the current situation with NVCR news and stock market news.
We've gathered opinions of 7 analysts rating NVCR stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.